West Pharmaceutical
225 hedge funds and large institutions have $3.5B invested in West Pharmaceutical in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 72 increasing their positions, 93 reducing their positions, and 21 closing their positions.
62% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 21
18% more capital invested
Capital invested by funds: $2.95B → $3.5B (+$546M)
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
6% more funds holding
Funds holding: 213 → 225 (+12)
0.92% less ownership
Funds ownership: 93.48% → 92.56% (-0.92%)
23% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 93
Top Buyers
Top Sellers
WST Hedge Fund Activity: Q4 2014 in Review
225 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2014, worth a combined $3.5B — up 18% from $2.95B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new WST positions and 21 closed out — a net gain of 13 holders — while 72 added to existing stakes and 93 trimmed.
The largest buyer was RS Investment Management, adding an estimated $23.9M. The largest seller was Granahan Investment Management, cutting an estimated $27.8M.
- 225 institutional investors held West Pharmaceutical (WST) as of Q4 2014, up from 213 in Q3 2014.
- Funds reported $3.5B of West Pharmaceutical stock for Q4 2014, up 18% quarter-over-quarter.
- 34 funds opened new West Pharmaceutical positions in Q4 2014 and 21 closed out, a net change of +13 holders.
- The largest West Pharmaceutical buyer in Q4 2014 was RS Investment Management, an estimated $23.9M added.
- The largest West Pharmaceutical seller in Q4 2014 was Granahan Investment Management, an estimated $27.8M sold.
Based on aggregated 13F filings for Q4 2014.